AB2 Bio
ID: 6959104AB2 Bio is a Lausanne-based medical diagnostics company involved in drug discovery and development for therapeutic solutions for inflammatory diseases founded in 2010 by Barthelemy Helg.
1
Funding Rounds
$20.8m
Money raised
Recent Funding Rounds
Overview
AB2 Bio is a Lausanne-based medical diagnostics company involved in drug discovery and development for therapeutic solutions for inflammatory diseases founded in 2010 by Barthelemy Helg.
- Websites:
- Headquarters: Lausanne
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Av***** Ka***** | - | - | - |
| Ba******** He** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| An**** Sl***** | - | - | - |
Funding series
Funding Series Analysis
The company AB2 Bio has raised a total of $20.79m in funding over 1 rounds.
Key Insights:
- AB2 Bio Series B round, January 2016: $20.79m
Industries
AB2 Bio is active in the following industries: